Rocket Lab's Financial Triumph Overshadowed by Launch Vehicle Delay

Rocket Lab posts record $602M revenue and $1.85B backlog for FY2025, but shares fall as Neutron rocket inaugural flight is delayed to late 2026.

Rocket Lab concluded its 2025 fiscal year with a powerful financial performance, yet investor sentiment remains tepid. The company posted record-breaking revenue figures and a surging order backlog, but these achievements are being weighed against a significant schedule slip for its next-generation Neutron rocket, highlighting the classic tension between near-term execution and long-term development risk in the aerospace sector.

Operational Execution and Strategic Moves

Beyond the headline development program, Rocket Lab's operational tempo remains high. On February 27, the company successfully completed its second hypersonic test mission for the U.S. Department of Defense within three months, maintaining a 100% success rate for its HASTE program. Furthermore, a new contract with BlackSky was secured for four additional launches using the proven Electron rocket.

Strategically, the acquisition of Optical Support, Inc. (OSI) was finalized. This move is designed to strengthen supply chains for critical optical precision systems, which are vital for both national security interests and commercial satellite constellations. Progress continues on the NASA Mars mission as well; the two satellites constructed by Rocket Lab have successfully completed their commissioning phase.

Current planning indicates these satellites will begin their journey to Mars in November 2026, with an expected arrival in September 2027. Looking ahead, management has set a revenue target of up to $200 million for the first quarter of 2026.

Record Financial Metrics and Investor Skepticism

A review of the full-year 2025 results reveals substantial growth. The company achieved record revenue of $602 million, representing a 38% year-over-year increase. The fourth quarter was particularly strong, contributing $180 million. A key indicator of future revenue, the backlog of orders, swelled to an all-time high of $1.85 billion by the end of 2025—a massive 73% jump from the previous year.

Despite this fundamental strength, Rocket Lab's shares have faced considerable pressure. Following a decline of nearly five percent on Friday, the stock's losses over the past 30 days have accumulated to over 20 percent. This market reaction suggests investors are currently assigning greater weight to development challenges than to the robust financial metrics.

Neutron Rocket Timeline Pushed Back

The primary focus of investor concern is the Neutron medium-lift launch vehicle, a cornerstone of the company's growth strategy. Rocket Lab has announced a revised schedule, with the inaugural flight now targeted for the fourth quarter of 2026. This delay stems from a tank failure during testing, which the company attributed to a manufacturing defect.

To enhance reliability, Rocket Lab is transitioning production to an automated fiber placement process and implementing minor design modifications. While this transparent approach to problem-solving is standard in the industry, it serves as a stark reminder of the inherent risks and substantial capital investment required in rocket development before a new vehicle achieves operational status. The question for the market is whether the company's current operational cash flow and contract wins can sufficiently offset the skepticism surrounding these high-stakes, long-cycle projects.